Hosted on MSN1d
Syros cut to neutral by H.C. Wainwright on failed drug study
H.C. Wainwright has downgraded Syros Pharmaceuticals (NASDAQ:SYRS) to neutral from buy, citing Tuesday’s announcement that a ...
Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop
Ardelyx (NASDAQ:ARDX) shares were down over 5% after H.C. Wainwright downgraded the rating for the biopharmaceutical firm, ...
electroCore price target raised to $22 from $15 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on electroCore (ECOR) to $22 from $15 and keeps a Buy rating on the shares after the firm ...
Hut 8 price target raised to $35 from $26 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Hut 8 (HUT) to $35 from $26 and keeps a Buy rating on the shares. The company reported ...
H.C. Wainwright Maintains ‘Buy’ Rating on Spectral AI, Inc. (MDAI) with $3.50 Price Target After Strong Q3 Results and Regulatory Progress
We recently compiled a list of the 15 AI News That Should Not Be Ignored. In this article, we are going to take a look at ...
Syros Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright downgraded Syros Pharmaceuticals (SYRS) to Neutral from Buy with a price target of $1, down from $6, after ...
MARA Holdings Faces Mixed Analyst Sentiment: Revenue Miss And Conservative Forecasts Amid Bitcoin Rally
MARA shares down as Q3 earnings miss estimates with lower revenue and adjusted loss, analysts maintain mixed views and price ...
Seeking Alpha on MSN2d
Phunware stock slides after downgrade to Neutral at H.C. Wainwright
Phunware (NASDAQ:PHUN) shares retreated 11% in Tuesday late morning trading after H.C. Wainwright & Co. downgraded the application software company to Neutral from Buy, as analyst Scott Buck became ...
Seeking Alpha3d
Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop
Ardelyx (NASDAQ:ARDX) shares were down over 5% after H.C. Wainwright downgraded the rating for the biopharmaceutical firm, saying that it anticipates a substantial drop in the company's kidney ...
bovnews14h
Lexicon Pharmaceuticals Inc (LXRX) Stock Sees Market Value Hit $394.03 million: What Are the Implications?
On Wednesday, Lexicon Pharmaceuticals Inc (LXRX) stock saw a decline, ending the day at $1.09 which represents a decrease of $-0.10 or -8.40% from the prior close of $1.19. The stock opened at $1.18 ...
Bitcoin Miners Hive Digital, Hut 8, Bitfarms To Report Earnings As Future Of Crypto 'Has Never Been Brighter'
Bitcoin (CRYPTO: BTC) has soared to all-time highs following Donald Trump's election win, also lifting Bitcoin mining stocks on a wave of positive sentiment.
bovnews1d
What’s Fueling Kopin Corp (KOPN) Stock’s -39.18% Loss Below Its 200-Day SMA?
On Tuesday, Kopin Corp (KOPN) stock saw a decline, ending the day at $0.73 which represents a decrease of $-0.02 or -2.67% from the prior close of $0.75. The stock opened at $0.77 and touched a low of ...